TABLE 2.
Priming of CD8+ and CD4+ T cells and antibodies in mice by HIV gag DNAa
DNA dose (ng) | % of cells specific for Gag
|
|||||||
---|---|---|---|---|---|---|---|---|
CD8+
|
CD4+
|
|||||||
Saline
|
PLG
|
Saline
|
PLG
|
|||||
Expt 1 | Expt 2 | Expt 1 | Expt 2 | Expt 1 | Expt 2 | Expt 1 | Expt 2 | |
0 (control) | 0.1 | 0.0 | nd | nd | 0.1 | 0.3 | nd | nd |
1 | 0.1 | 0.1 | 7.2 | 13.9 | 0.1 | 0.2 | 0.9 | 1.1 |
10 | 0.2 | 0.2 | 8.4 | 13.5 | 0.1 | 0.3 | 1.1 | 0.7 |
10,000 | 21.6 | 24.1 | nd | nd | 1.9 | 1.9 | nd | nd |
Groups of 10 CB6 F1 mice were immunized a single time with the indicated doses of DNA in saline or PLG/CTAB or unimmunized (control). At 28 days, mice were challenged with recombinant vaccinia virus encoding HIV gag, and 5 days later spleens were harvested for analysis of IFN-γ production, as measured by flow cytometry. Data are presented as mean percentages of CD4+ or CD8+ T cells specific for Gag for two separate experiments, each involving pools of five spleens. nd, not done.